École de médecine

Faculté de médecine de l'Université d'Istanbul Cerrahpaşa, 2002

 

Formation post-universitaire

Faculté de médecine de l'Université d'Istanbul Cerrahpaşa, Département de médecine interne, 2008

Hôpital de formation et de recherche Haydarpaşa Numune, département de gastro-entérologie, 2011

 

Expérience professionnelle

Faculté de médecine de l'Université d'Istanbul Cerrahpaşa, 1996-2002

Faculté de médecine de l'Université d'Istanbul Cerrahpaşa, Département de médecine interne (formation en résidence), 2002-2007

Hôpital de formation et de recherche Haydarpaşa Numune, Clinique de gastro-entérologie (formation de sous-spécialité en gastro-entérologie), 2008-2011

Faculté de médecine de l'université Bezmialem Vakif, département de gastro-entérologie (cours de CPRE et de SUE), 2011-2012

Faculté de médecine de l'université de Dicle, département de médecine interne (département de gastro-entérologie), service obligatoire, 2012-2014

Professeur associé, 2012

Faculté de médecine de l'université de Dicle, département de gastro-entérologie (professeur associé), 2013-2014

Hôpital de formation et de recherche de l'université Medeniyet d'Istanbul Göztepe, clinique de gastro-entérologie (professeur associé et professeur), 2014-2019

Formation à la transplantation hépatique à l'hôpital Florence Nightingale d'Istanbul (unité de transplantation), juin 2016

 

Intérêts médicaux

Maladie de Crohn

Colite ulcéreuse

Maladie cœliaque

Reflux

Gastrite

Hépatite chronique B, C

Helicobacter Pylori

Cirrhose du foie

Foie gras

Constipation

Diarrhée

Syndrome de l'intestin irritable (SII)

Allergie alimentaire

 

Expérience particulière

CPRE (Cholangiopancréatographie rétrograde endoscopique)

EUS (échographie endoscopique)

EMR (résection muqueuse endoscopique)

ESD (Dissection sous-muqueuse endoscopique)

POEM (Traitement endoscopique de l'achalasie)

Fibroscan

ARMA (Traitement endoscopique du reflux)

 

Scientific Publications

A. Articles Published in International Refereed Journals

A1: Senates E, Yilmaz Y, Colak Y, Ozturk O, Altunoz Me, Kurt R, Ozkara S, Aksaray S, Tuncer I, Ovunc Ao. Serum Levels of Hepcidin in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Metab Syndr Relat Disord. 2011 Aug;9(4):287-90. Doi: 10.1089/Met.2010.0121. Epub 2011 Mar 21.

A2: Ince AT, Senateş E, Bahadir O, Coşgun S, Güneş P, Yildiz E, Ovünç Ao. Conventional Video-Gastroscopes For The Recognition Of Early Gastric Cancers. Hepatogastroenterology. 2011 May-Jun;58(107-108):1081-5.

A3: Ince At, Güneş P, Senateş E, Sezikli M, Tiftikçi A, Ovünç O. Can An Immunohistochemistry Method Differentiate Intestinal Tuberculosis from Crohn's Disease In Biopsy Specimens? Dig Dis Sci. 2011 Apr;56(4):1165-70. Doi: 10.1007/S10620-010-1399-7. Epub 2010 Sep 8.

A4: Calhan T, Senateş E, Cebeci E, Zuhur Ss, Ozbakır F, Görpe U. A Comparison Of Antineutrophil Cytoplasmic Antibody Prevalence in Patients Treated And Untreated For Hyperthyroidism. Endocrine. 2010 Oct;38(2):199-205. Doi:10.1007/S12020-010-9373-X. Epub 2010 Jul 11.

A5: Yilmaz Y, Senates E, Ayyildiz T, Colak Y, Tuncer I, Ovunc Ao, Dolar E, Kalayci C. Characterization of Nonalcoholic Fatty Liver Disease Unrelated To the Metabolic Syndrome. Eur J Clin Invest. 2012 Apr;42(4):411-8. Doi: 10.1111/J.1365-2362.2011.02597.X. Epub 2011 Sep 13.

A6: Hatemi AI, Senateş E, Dobrucali A, Göksel S. Collagenous Colitis: A Retrospective Survey of Patients with Chronic Diarrhea. Hepatogastroenterology. 2011 Nov-Dec;58(112):1963-7. Doi: 10.5754/Hge11228.

A7:Şenateş E, Masatlıoğlu HS, Akdoğan MF, Kurtuluş D, Atasoy MM, Övünç AOK, "A Polyarteritis Nodosa Case Mimicking Pyelonephritis, then Misdiagnosed as Inflammatory Bowel Disease", Turk J Phys Med Rehab 2013;59:79-82. Doı:10.4274/Tftr.61214.

A8: Yeşil A, Senateş E, Bayoğlu IV, Erdem ED, Demirtunç R, Kurdaş Övünç AO. Red Cell Distribution Width: A Novel Marker of Activity in Inflammatory Bowel Disease. Gut Liver. 2011 Dec;5(4):460-7. Doi: 10.5009/Gnl.2011.5.4.460. Epub 2011 Nov 21.

A9: Colak Y, Ozturk O, Senates E, Tuncer I, Yorulmaz E, Adali G, Doganay L, Enc Fy. SIRT1 As a Potential Therapeutic Target for Treatment of Nonalcoholic Fatty Liver Disease. Med Sci Monit. 2011 May;17(5):Hy5-9. Review.

A10: Colak Y, Senates E, Ozturk O, Yilmaz Y, Coskunpinar E, Kahraman OT, Sahin O, Zemheri E, Enc FY, Ulasoglu C, Kiziltas S, Kurdas OO, Tuncer I. Plasma Fibrinogen-Like Protein 2 Levels in Patients With Non-Alcoholic Fatty Liver Disease. Hepatogastroenterology. 2011 Nov-Dec;58(112):2087-90. Doi:

10.5754/Hge11248.

A11: Güzelbulut F, Ovünç AO, Çetinkaya ZA, Senates E, Gökden Y, Saltürk AG, Sezikli M, Ozkara S, Cetinkaya F. Comparison of The Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B. Hepatogastroenterology. 2012 Mar-Apr;59(114):477-80. Doi: 10.5754/Hge11426.

A12: Ozdil K, Calhan T, Sahin A, Senates E, Kahraman R, Yüzbasioglu B, Demirdag H, Demirsoy H, Sökmen MH. Levofloxacin Based Sequential and Triple Therapy Compared With Standard Plus Probiotic Combination for Helicobacter Pylori Eradication. Hepatogastroenterology. 2011 Jul-Aug;58(109):1148-52. Doi: 10.5754/Hge11075.

A13: Yilmaz Y, Eren F, Ayyildiz T, Colak Y, Kurt R, Senates E, Tuncer I, Dolar E, Imeryuz N. Serum Pigment Epithelium-Derived Factor Levels are Increased in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease and Independently Associated with Liver Steatosis. Clin Chim Acta. 2011 Nov 20;412(23-24):2296-9. Doi: 10.1016/J.Cca.2011.08.025. Epub 2011 Aug 24.

A14: Sökmen HM, Ozdil K, Calhan T, Sahin A, Senateş E, Kahraman R, Niğdelioğlu A, Zemheri E. Situs Inversus Totalis and Secondary Biliary Cirrhosis: A Case Report. Comp Hepatol. 2011 Aug 3;10:5. Doi: 10.1186/1476-5926-10-5.

A15: Yilmaz Y, Eren F, Kurt R, Yonal O, Polat Z, Senates E, Bacha M, Imeryuz N. Serum Galectin-3 Levels in Patients with Nonalcoholic Fatty Liver Disease. Clin Biochem. 2011 Aug;44(12):955-8. Doi: 10.1016/J.Clinbiochem.2011.05.015. Epub 2011 May 24.

A16: Masatlioglu S, Seyahi E, Tahir Turanli E, Fresko I, Gogus F, Senates E, Oguz Savran F, Yazici H. A Twin Study in Behçet's Syndrome. Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S62-6. Epub 2010 Sep 24.

A17: Yilmaz Y, Kurt R, Gurdal A, Alahdab Yo, Yonal O, Senates E, Polat N, Eren F, Imeryuz N, Oflaz H. Circulating Vaspin Levels and Epicardial Adipose Tissue Thickness are Associated with Impaired Coronary Flow Reserve in Patients With Nonalcoholic Fatty Liver Disease. Atherosclerosis. 2011 Jul;217(1):125-9. Doi: 10.1016/J.Atherosclerosis.2011.03.026. Epub 2011 Mar 29.

A18: Colak Y, Senates E, Coskunpinar E, Oltulu YM, Zemheri E, Ozturk O, Doganay L, Mesci B, Yilmaz Y, Enc FY, Kiziltas S, Ulasoglu C, Tuncer I. Concentrations of Connective Tissue Growth Factor in Patients with Nonalcoholic Fatty Liver Disease: Association With Liver Fibrosis. Dis Markers. 2012;33(2):77-83. Doi: 10.3233/Dma-2012-0907.

A19: Colak Y, Senates E, Ozturk O, Doganay Hl, Coskunpinar E, Oltulu YM, Eren A, Sahin O, Ozkanli S, Enc Fy, Ulasoglu C, Tuncer I. Association Of Serum Lipoprotein-Associated Phospholipase A2 Level With Nonalcoholic Fatty Liver Disease. Metab Syndr Relat Disord. 2012 Apr;10(2):103-9. Doi: 10.1089/Met.2011.0111. Epub 2011 Nov 23.

A20: Altunöz ME, Senateş E, Yeşil A, Calhan T, Ovünç AO. Patients With Inflammatory Bowel Disease Have a Lower Response Rate To HBV Vaccination Compared To Controls. Dig Dis Sci. 2012 Pr;57(4):1039-44. Doi: 10.1007/S10620-011-1980-8. Epub 2011 Dec 7.

A21: Colak Y, Tuncer I, Senates E, Ozturk O, Doganay L, Yilmaz Y. Nonalcoholic Fatty Liver Disease: A Nutritional Approach. Metab Syndr Relat Disord. 2012 Jun;10(3):161-6. Doi: 10.1089/Met.2011.0145. Epub 2012 Mar 6. Review.

A22: Şenateş E, Çolak Y, Erdem ED, Yeşil A, Coşkunpınar E, Şahin Ö, Altunöz ME, Tuncer I, Kurdaş Övünç AO. Serum Anti-Müllerian Hormone Levels are Lower In Reproductive-Age Women With Crohn's Disease Compared To Healthy Control Women. J Crohns Colitis. 2013 Mar;7(2):E29-34. Doi: 10.1016/J.Crohns.2012.03.003. Epub 2012 Apr 1.

A23: Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman Ot, Mesci B, Ulasoglu C, Tuncer I. Assessment Of Endothelial Function in Patients With Nonalcoholic Fatty Liver Disease. Endocrine. 2013 Feb;43(1):100-7. Doi: 10.1007/S12020-012-9712-1. Epub 2012 Jun 3.

A24: Colak Y, Karabay CY, Tuncer I, Kocabay G, Kalayci A, Senates E, Ozturk O, Doganay Hl, Enc FY, Ulasoglu C, Kiziltas S. Relation Of Epicardial Adipose Tissue And Carotid Intima-Media Thickness In Patients with Nonalcoholic Fatty Liver Disease. Eur J Gastroenterol Hepatol. 2012 Jun;24(6):613-8. Doi:10.1097/Meg.0b013e3283513f19.

A25: Colak Y, Senates E, Ozturk O, Yilmaz Y, Zemheri E, Yilmaz Enc F, Ulasoglu C, Aksaray S, Bozbeyoglu Sg, Kiziltas S, Kurdas Oo, Tuncer I. Serum Concentrations Of Human Insulin-Like Growth Factor-1 And Levels Of Insulin-Like Growth Factor-Binding Protein-5 In Patients With Nonalcoholic Fatty Liver Disease: Association With Liver Histology. Eur J Gastroenterol Hepatol. 2012 Mar;24(3):255-61. Doi: 10.1097/Meg.0b013e32834e8041.

A26: Tabak O, Gelişgen R, Cicekçi H, Senateş E, Erdenen F, Müderrisoğlu C, Aral H, Uzun H. Circulating Levels Of Adiponectin, Orexin-A, Ghrelin And the Antioxidant Paraoxonase-1 in Metabolic Syndrome. Minerva Med. 2012 Aug;103(4):323-9.

A27: Calhan T, Kahraman R, Sahin A, Senates E, Doganay HL, Kanat E, Ozdil K, Sokmen HM. Efficacy Of Two Levofloxacin-Containing Second-Line Therapies For Helicobacter Pylori: A Pilot Study. Helicobacter. 2013 Apr 21. Doi:10.1111/Hel.12056.

A28: Yilmaz Y, Colak Y, Kurt R, Senates E, Eren F. Linking Nonalcoholic Fatty Liver Disease To Hepatocellular Carcinoma: From Bedside To Bench And Back. Tumori. 2013 Jan-Feb;99(1):10-6. Doi: 10.1700/1248.13781. Review.

A29: Yeşil A, Gönen C, Senateş E, Paker N, Gökden Y, Koçhan K, Erdem Ed, Gündüz F. Relationship Between Neutrophil Gelatinase-Associated Lipocalin (Ngal) Levels And Inflammatory Bowel Disease Type And Activity. Dig Dis Sci. 2013 Apr 30.

A30: Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman Ot, Erkalma Şenateş B, Tuncer I. Circulating Resistin is Elevated in Patients with Non-Alcoholic Fatty Liver Disease and is Associated With Steatosis, Portal İnflammation, İnsulin Resistance And Nonalcoholic Steatohepatitis Scores. Minerva Med. 2012 Oct;103(5):369-76.

A31: Yilmaz Y, Ozturk O, Alahdab Yo, Senates E, Colak Y, Doganay HL, Coskunpinar E, Oltulu YM, Eren F, Atug O, Tuncer I, Imeryuz N. Serum Osteopontin Levels As A Predictor Of Portal İnflammation İn Patients With Nonalcoholic Fatty Liver Disease. Dig Liver Dis. 2013 Jan;45(1):58-62. Doi: 10.1016/J.Dld.2012.08.017.

A32: Yilmaz Y, Eren F, Colak Y, Senates E, Celikel CA, Imeryuz N. Hepatic Expression And Serum Levels Of Syndecan 1 (CD138) in Patients with Nonalcoholic Fatty Liver Disease. Scand J Gastroenterol. 2012 Dec;47(12):1488-93. Doi:10.3109/00365521.2012.725093. Epub 2012 Nov 8.

A33: Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, Ozguneş N, Colak O, Gunduz A, Senates E, Ozaras R, Inci A, Tabak F. A New Model Using Platelet Indices to Predict Liver Fibrosis In Patients With Chronic Hepatitis B Infection. Wien Klin Wochenschr. 2013; 125(15-16)

A34: Yilmaz Y, Ayyildiz T, Akin H, Colak Y, Ozturk O, Senates E, Tuncer I, Dolar E. Gallstone disease does not predict liver histology in nonalcoholic Fatty liver disease. Gut Liver. 2014;8(3):313-7. doi: 10.5009/gnl.2014.8.3.313.

A35: Selvinaz Ozkara, Fugen Aker, Atakan Yesil, Ebubekir Senates, Ceren Canbey, Ali Yitik and Can Gonen. Re-Evaluation of Cases With Gastroenteropancreatic Neuroendocrine Tumors Between 2004 and 2012 According to the 2010 Criteria. Hepato-Gastroenterology 2013; 60:00-00 Doi 10.5754/Hge 13337.

A36: Kiziltas S, Ata P, Colak Y, Mesçi B, Senates E, Enc F, Ulasoglu C, Tuncer I,Oguz A. TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metab Syndr Relat Disord. 2014;12(3):165-70. doi: 10.1089/met.2013.0120. Epub 2014 Jan 20.

A37: Kadir Kayataş, Özhan Kaya, Ebubekir Şenateş, Atakan Yeşil, , Banu Erkalma Şenateş, Ezgi Ersoy Yeşil, Erdal Belen, Akın Dayan, Refik Demirtunç. Relationship between serum lipids and colon polyps: a pilot study. Acta Medica Mediterranea, 2014, 30: 57

A38: Yilmaz Y, Senates E, Yesil A, Ergelen R, Colak Y. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease. J Diabetes Complications. 2014 May-Jun;28(3):328-31. doi: 10.1016/j.jdiacomp.2014.01.013. Epub 2014 Jan 30.

A39: HLA DQB1 alleles are related with nonalcoholic fatty liver disease. Levent Doganay, Seyma Katrinli, Yasar Colak, Ebubekir Senates, Ebru Zemheri, Oguzhan Ozturk, Feruze Yilmaz Enc, Ilyas Tuncer, Gizem Dinler Doganay. Mol Biol Rep. DOI 10.1007/s11033-014-3688-2. Received: 21 September 2013 / Accepted: 20 August 2014.

A40: Colak Y, Yesil A, Mutlu HH, Caklili OT, Ulasoglu C, Senates E, Takir M, Kostek O, Yilmaz Y, Yilmaz Enc F, Tasan G, Tuncer I. A potential treatment ofnon-alcoholic fatty liver disease with SIRT1 activators. J Gastrointestin Liver Dis. 2014 Sep;23(3):311-319. doi: 10.15403/jgld.2014.1121.233.yck. Review.

A41: Ebubekir Şenateş, Abdullah Doğan, Banu Erkalma Şenateş, Erdal Bodakçı, Muhammet Bekçibaşı. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma. Infez Med. 2014;22(4):313-6.

A42. Ebubekir Şenateş, Yaşar Çolak, Atakan Yeşil, Ilyas Tuncer. Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C. Turk J Gastroenterol 2015; 26: 283-283. DOI: 10.5152/tjg.2014.0083.

A43. Banu Erkalma Şenateş, Abdullah Doğan, Ebubekir Şenateş. Symptomatic hypocalcaemia following intravenous administration of zoledronic acid in a female patient with osteoporosis. Acta Medica Mediterranea, 2015, 31: 895.

A44. Oguzhan Ozturk, Yasar Colak, Ebubekir Senates, Yusuf Yilmaz, Celal Ulasoglu, Levent Doganay, Seyma Ozkanli, Yasemin Musteri Oltulu, Ender Coskunpinar, Ilyas Tuncer. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol. 2015 14;21(26):8096-102. doi: 10.3748/wjg.v21.i26.8096.

A45. Meric K, Bakal N, Şenateş E, Aydın S, Kılıçoğlu ZG, Bahadır Ülger FE, Yencilek E, Erkalma Şenateş B, Şimşek M. Comparison of a 4-Day versus 2-Day Low Fiber Diet Regimen in Barium Tagging CT Colonography in Incomplete Colonoscopy Patients. Gastroenterol Res Pract. 2015;2015:609150. doi: 10.1155/2015/609150.

A46. Çolak Y, Bozbey G, Erim T, Caklili OT, Ulasoglu C, Senates E, Mutlu HH, Mesci B, Doğan MS, Tasan G, Enc FY, Tuncer I. Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease. J Neurogastroenterol Motil. 2016 Jul 30;22(3):470-6. doi: 10.5056/jnm15159.

A47. Sargin F, Yildiz D, Aydin OA, Mete B, Gunduz A, Karaosmanoglu HK, Yemisen M, Yazici S, Bolukcu S, Durdu B, Senates E, Ozaras R, Dokmetas I, Tabak F. Changes in HIV demographic patterns in a low prevalence population: no evidence of ashift towards men who have sex with men. Int J Infect Dis. 2016 Jul;48:52-6. doi:10.1016/j.ijid.2016.05.006.

A48. Yilmaz B, Can G, Ucmak F, Arslan AO, Solmaz I, Unlu O, Düzenli S, Korkmaz U, Kurt M, Senates E. Polymorphisms in the IL28B gene (rs12979860, rs8099917) and the virological response to pegylated interferon therapy in hepatitis D virüs patients. Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):206-10.

A49. Mehmet Veysi Bahadır, Mesut Gül, Ebubekir Şenateş, Cemil Göya, Abdullah Oğuz, Hüseyin Büyükbayram, Halil Kömek, Eyyüp Öner, Bilsel Baç. A Rare Duodenal Mass, Brunneroma: Case Report. Journal of Gastroenterology and Hepatology Research. Journal of GHR 2016 June; 5(3): 2096-2099 doi: 10.17554/j.issn.2224-3992.2016.05.614

A50. Uçmak F, Ekin N, İbiloğlu İ, Arslan S, Kaplan İ, Şenateş E. ProphylacticAdministration of Silybin Ameliorates L-Arginine-Induced Acute Pancreatitis. Med Sci Monit. 2016 Oct 11;22:3641-3646.

A51. Feyzullah Uçmak, İhsan Solmaz, Nazim Ekin, İbrahim Kaplan, Elif Tuğba Tuncel, Ebubekir Şenateş, Kendal YalçIn. The Status Of Oxidative Stress And Antioxidant Defense In Patients With Chronic Hepatitis D. Acta Medica Mediterranea, 2016, 32: 1865 DOI: 10.19193/0393-6384_2016_6_175.

A52. Suleyman Orman, Ebubekir Senates, Celal Ulasoglu, and Ilyas Tuncer (2016) Real-life data on the accuracy of imaging modalities in choledocholithiasis. Int Surg In-Press. https://doi.org/10.9738/INTSURG-D-16-00005.1

A53. Denli Yalvaç EŞ, Aldağ M, Kocaaslan C, Şenateş E, Aydın E. Acute pancreatitis after coronary artery bypass surgery treated by plasmapheresis. Turk J Gastroenterol. 2018 Jan;29(1):103-105. doi: 10.5152/tjg.2017.17427.

A54. Yurdaydın C, Tabak F, Kaymakoğlu S, Akarsu M, Akıncı EG, Akkız H, Alkım C, Çekin AH, Çuvalcı NÖ, Demir K, Değertekin B, Dökmetaş İ, Ersöz G, Hizel K,Kandemir FÖ, Önlen Y, Sonsuz A, Şenateş E, Tosun S, Tözün N, Idilman R, Guidelines Study Group VH. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines. Turk J Gastroenterol. 2017 Dec;28(Suppl 2):84-89. doi: 10.5152/tjg.2017.20.

A55. Tabak F, Yurdaydın C, Kaymakoğlu S, Akarsu M, Akıncı EG, Akkız H, Alkım C, Çekin AH, Çuvalcı NÖ, Demir K, Değertekin B, Dökmetaş İ, Ersöz G, Hizel K, Kandemir FÖ, Önlen Y, Sonsuz A, Şenateş E, Tosun S, Tözün N, Idilman R, Guidelines Study Group VH. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines. Turk J Gastroenterol. 2017 Dec;28(Suppl 2):73-83. doi: 10.5152/tjg.2017.19.

A56. Şenateş E. Toward a new ultrasound-based imaging method for the diagnosis of acute pancreatitis: A preliminary study suggesting that it may be feasible. Turk J Gastroenterol. 2018 May;29(3):256-258. doi: 10.5152/tjg.2018.24418.

A57. Faruk Kilinc, 
Ebubekir Senates, 
Fatih Demircan
, Zafer Pekkolay, 
Nevzat Gozel
, Mehmet Guven, 
Ibrahim Halil Bahcecioglu, Alpaslan Kemal Tuzcu. Are There Differences in the Management of Acute Pancreatitis Cases Due to Severe Hypertriglyceridemia in Pregnant Women? Med Sci Monit, 2018; 24: DOI: 10.12659/MSM.910343.

 

B. Papers Presented at International Scientific Meetings and Published in Proceedings

B1: Kurdas AOÖ, Guzelbulut F, Gökden Y, Senates E, Çetinkaya Za, Degirmenci Ag, Yasar B, The 60th Annual Meeting Of The American Association For The Study Of Liver Diseases Konferansı Dahilinde "Supplement To Hepatology" Bildiri Kitapçığındaki "Pegıfs are not Satisfactory In Genotype D Chronic HBV Infection", 523a Pp., Boston, Amerika Birleşik Devletleri, 30 Ekim-3 Kasım 2009.

B2: Hatemi I, Dobrucali A, Senates E, Goksel S, “Falk Symposium 169: Inflammation in The Intestinal Tract: Pathogenesis and Treatment” Konferansı Dahilinde "Falk Symposium 169:Inflammation in The Intestinal Tract: Pathogenesis And Treatment Abstracts" Bildiri Kitapçığındaki "Collagenous Colitis: A Retrospective Survey Of Chronic Diarrhea", 26 Pp., Kiev, Ukrayna, Mayıs 2009.

B3: Hatemi I, Baysal B, Senates E, Erzin Y, Celik A. “Digestive Disease Week and 108th Annual Meeting of the AGA Institute” Konferansı Dahilinde "Supplement To Gastroenterology" Bildiri Kitapçığındaki "Azathioprine Toxicity in The Treatment of Inflammatory Bowel Disease: Outpatient Clinic Experience Of Seven Years", A-668 Pp., Washington, DC, Amerika Birleşik Devletleri, Mayıs 2007.

B4: Baysal B, Hatemi I, Senates E, Erzin Y, Ceik A. “Digestive Disease Week and 108th Annual Meeting of the AGA Institute” Konferansı Dahilinde "Supplement To Gastroenterology" Bildiri Kitapçığındaki "Bone Mineral Density in Corticosteroid Naive Crohn's Disease Patients", A668-A669 Pp., Washington, Dc, Amerika Birleşik Devletleri, Mayıs 2007.

B5: Hatemi İ, Hatemi G, Senates E, Baysal B, Erzin Y, Celik A.F. “Digestive Disease Week 2008” Konferansı Dahilinde "Digestive Disease Week 2008 Accepted Abstracts" Bildiri Kitapçığındaki "Low Dose Thalidomide in Immunosuppressive Unresponsive IBD; Effectiviness And Side Effects", 1 Pp., San Diego, CAa, Amerika Birleşik Devletleri, Mayıs 2008.

B6: Senates E, Yumuk V. “19th World Diabetes Congress” Konferansı Dahilinde "19th World Dıabetes Congress Abstract Book" Bildiri Kitapçığındaki "Are We Delayed To Start Insulin Therapy In People With Type 2 Diabetes?", 344 Pp., Cape Town, Güney Africa, Aralık 2006.

B7: Özdemir S, Kantarcı F, Karadağ B, Baran A, Senates E, Hatemi İ, Mihmanli I, Vural V.A., Akın P, Domaniç N, 18th Internatıonal Postgraduate Course Of The Internatıonal Assocıatıon Of Surgeons, Gastroenterologısts And Oncologısts Konferansı Dahilinde "Hepato-Gastroenterology Supplement I Abstracts" Bildiri Kitapçığındaki "Carotid Atherosclerosis In Cirrhotic Patients", A325 Pp., İstanbul, Türkiye, Ekim 2008.

B8: Yilmaz Y, Senates E, Ayyildiz T, Colak Y, Tuncer I, Kurdas A.O., Dolar E, Kalayci C, Digestive Disease Week 2011 Konferansı Dahilinde "Digestive Disease Week 2011 Abstracts" Bildiri Kitapçığındaki "Characterization Of Nonalcoholic Fatty Liver Disease Unrelated to the Metabolic Syndrome", S-988-S989 Pp., Chicago, Il, Amerika Birleşik Devletleri, Mayıs 2011.

B9: Ovunc AOK, Guzelbulut F, Senates E, Gökden Y,Salturk AGD, Çetinkaya ZA, Sezikli M, Ozkara S, Çetinkaya F. Digestive Disease Week 2011 Konferansı Dahilinde "Digestive Disease Week 2011 Aasld Abstracts" Bildiri Kitapçığındaki "Comparison Of The Efficacy Of Entecavir And Tenofovir in Chronic Hepatitis B Patients with High Viral Load And/Or High Fibrosis Scores At Week 48 Of Therapy", S-930-S-931 Pp., Chicago, Il, Amerika Birleşik Devletleri, Mayıs 2011.

B10: Ozdil K, Calhan T, Sahin A, Senates E, Kahraman R, Demirsoy H, Sokmen HM. 19th United European Gastroenterology Week Konferansı Dahilinde "19th United European Gastroenterology Gut October 2011 Vol 60 Supplements 3" Bildiri Kitapçığındaki "Levofloxacın Based Sequentıal And Trıple Therapy Compared Wıth Standard Plus Probıotıc Combınatıon For Helıcobacter Pylorı Eradıcatıon", Op262 A60 Pp., Stockholm, İsveç, Ekim 2011.

B11: Yilmaz Y, Kurt R, Gürdal A, Alahdab Y.O., Yonal O, Senates E, Polat N, Eren F, Imryuz N, Oflaz H., 19th United European Gastroenterology Week Konferansı Dahilinde "19th United European Gastroenterology Week Gut October 2011 Vol 60 Supplements 3" Bildiri Kitapçığındaki "Circulating Vaspin Levels and Epicardial Adipose Tissue Thickness are Associated with Impaired Coronary Flow Reserve in Patıents With Nonalcoholıc Fatty Liver Disease", P0156 A136 Pp., Stockholm, İsveç, Ekim 2011.

B12: Tuncer I, Colak Y, Ozdamarlar U, Senates E, Ozturk O, Yesil A, Kahraman O.T., Oltulu Y.M., Coskunpinar E, Enc F.E., Kurdas Oo, Ulasoglu C., 8th Metabolic Syndrome Symposium Konferansı Dahilinde "Abstracts For The 8th Metabolic Syndrome Symposium" Bildiri Kitapçığındaki "Non-Invasive Detection Of Endothelial Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease", 576 Pp., Antalya, Türkiye, 28 Nisan-1 Mayıs 2011.

B13: Çolak Y, Senates E, Ozturk O, Yilmaz Y, Zemheri E, Aksaray S, Enc FY, Ulasoglu C, Kiziltas S, Kurdas OO, Tuncer I. 8th Metabolic Syndrome Symposium Konferansı Dahilinde "Abstracts For the 8th Metabolic Syndrome Symposium" Bildiri Kitapçığındaki "Serum Concentrations Of Human Insulin-Like Growth Factor-1 And Levels Of Insulin-Like Growth Factor binding Protein-5 in Patients With Nonalcoholic Fatty Liver Disease: Association With Liver Histology", 576-577 Pp., Antalya, Türkiye, 28 Nisan-1 Mayıs 2011.

B14: Y. Yilmaz, F. Eren, R. Kurt, O. Yonal, Z.Polat, E. Senates, M. Bachae, N. Imeryuz. 19th UEGW Konferansı Dahilinde "19th UEGW Stockholm, Gut October 2011 Vol 60 Supplements 3" Bildiri Kitapçığındaki "Serum Galectin-3 Levels are Associated With Bmı But Are Not Altered in Patients With Nonalcoholic Fatty Liver Disease", P0157 A137 Pp., Stockholm, İsveç, Ekim 2011.

B15. Ebubekir Senates, Yasar Colak, Emrullah D. Erdem, Atakan Yesil, Ender Coskunpinar,Mustafa E. Altunoz, Onder Sahin, Ilyas Tuncer, Ayse O. Kurdas Ovunc Serum Anti-Müllerian Hormone Levels Are Lower in Reproductive-Age Women With Crohn's Disease Compared to Healthy Control Women . Digestive Disease Week 2012 Ttarihinde Yapılan Kongrenin "Supplement To Gastroenterology" Bildiri Kitapçı. 19-22 Mayıs 2012 San Diego, California. ABD.

B16: Bilgül Mete, Bahadır Ceylan, Nail Özgüneş, Alper Gündüz, Hayat Kumbasar Karaosmanoğlu, Atahan Çağatay, Kadir Göktürk, Levent Erdem, Funda Koçak, Levent Görenek, Turan Aslan, Ebubekir Senates, Resat Ozaras, Onur Colak, Fehmi Tabak. Entecavir Vs. Tenofovir in Treatment-Naive Chronic Hepatitis B Patients: Rela World Data From The Realist Study. Supplement: The 63rd Annual Meeting Of The American Association For The Study Of Liver Diseases: The Liver Meeting 2012. Volume 56, Issue Supplement S1, Pages 191a–1144a,October 2012. 9-13 October, Boston, USA.

B17: Y. Yilmaz F. Eren, Y. Colak, E. Senates, C.A. Celikel, N. Imeryuz. “Hepatıc Expressıon And Serum Levels Of Syndecan 1 (CD138) In Patients with Nonalcoholıc Fatty Liver Dısease” Journal Of Hepatology, Supplement No 1. Vol 58. Page:547 EASL 2013 Congress 23-28 April 2013 Amsterdam, Netherland.

B18: Y. Yilmaz, T. Ayyildiz, H. Akin, Y. Colak, O. Ozturk, E. Senates, I. Tuncer, E. Dolar. Gallstone Disease is not Associated with Liver Fibrosis and Nonalcoholic Steatohepatitis in Nonalcoholic Fatty Liver Disease. Journal of Hepatology, Supplement No 1. Vol 58. Page:563 EASL 2013 Congress 23-28 April 2013 Amsterdam, Netherland.

B19: Y. Yilmaz, T. Ayyildiz, Y. Colak, E. Senates, M. Arabul, B. Unsal, I. Tuncer, E. Dolar. Hypothyroidism is not Associated with Specific Histological Features or Severity Of Non-Alcoholic Fatty Liver Disease. Journal Of Hepatology, Supplement No 1. Vol 58. Page:564 Easl 2013 Congress 23-28 Aprıl 2013 Amsterdam, Netherland.

B20: Safak Kiziltas, Pinar Ata, Yasar Colak, Banu Mesci, Ebubekir Senates, Feruze Enc, Celal Ulasoglu, Ilyas Tuncer, Aytekin Oguz. Is The Tlr-4 Gene Polymorphism Play A Protective Role İn The Development of NAFLD in Humans ? Digestive Diseases Week 2013 18-21 May 2013, Orlando, Florida, USA (Poster Code: Tu 243; Aga Abstracts).

B21: F. Tabak, B. Mete, B. Ceylan, N. Ozgunes, A. Gunduz, H. Karaosmanoglu, A. Cagatay, K. Gokturk, L. Erdem, F. Kocak, E. Senates, R. Ozaras. Entecavir versus tenofovir in treatment-naïve Chronic Hepatitis B patients: THIRD YEAR results of a Real-world Study. IDweek 2-6 October, 2013, San Francisco, Ca, USA.

B22: Yasar Colak, Gulcin Bozbey, Ebubekir Senates, Levent Doganay, Ender Coskunpinar, Oguzhan Ozturk, Banu Mesci, Ihsan Kuru, Guralp Tasan, Yusuf Yilmaz, Ilyas Tuncer. Evaluation of gallbladder kinetics in patients with nonalcoholic fatty liver disease. The Liver Meeting 2013 (AASLD Congress). November 1-5, 2013, Washington DC, USA.

 

C. Articles Published in National Refereed Journals

C1. Şenateş E, Çolak Y, Coşgun S, Altunöz M.E. Yılma Y, Öztürk O, Övünç A.O.K., "Patients Perceive Unsedated Upper Gastrointestinal Endoscopy as More Difficult Than It Actually Is", Endoscopy, pp. 52-55, 2011.

C2. Şenateş E, İnce A.T. "Early Gastric Cancer", Current Gastroenterology Journal, 2011; 15 (3): 161-6.

C3. Tabak Ö, Şenateş E, Arslan F, Özaras R, "Etiology of Polyserositis in Hospitalized Patients: Evaluation of 40 Patients", Academic Gastroenterology Journal, 2011; 10 (1): 14-17.

C4. Yeşil E.E., Şenateş E, Yeşil A, Can Sevinç C, Tufan F, Özdemir A, "Is Serum Homocysteine Level Elevated in Patients Using Proton Pump Inhibitors?", Academic Gastroenterology Journal, 2010; 9 (3): 105-109.

C5. İnce A.T, Şenateş E, Akçay S.Ş., Tekin Z.S., Sezikli M, Coşgun S, Altunöz M.E., "Toxin A and B Frequency in Mildly And Moderately Active Inflammatory Bowel Disease Patients". Academic Gastroenterology Journal, 2011; 10 (1): 18-22.

C6. Yıldız P, Şenateş E, Yeşil A, Bayoğlu İ.V., Yeşil E.E,. Demirtunç R., "Frequency of Gallbladder Stones in Patients with Cirrhosis Due to Chronic Hepatitis B and Chronic Hepatitis C". Academic Gastroenterology Journal, 2011; 10 (2): 56-60.

C7. Sezikli M, Çetinkaya Za, Güzelbulut F, Gökden Y, Yaşar B, Şenateş E, İnce At, Kurdaş Aoö, "How Suitable Are Patients Diagnosed with Hepatocellular Carcinoma for Liver Transplantation at the Time of Diagnosis?" Academic Gastroenterology Journal, 2010; 9 (2): 55-59.

C8. Yeşil A, Şenateş E, Kayataş K, Et Al. Types And Frequencies Of Extraintestinal Involvement In Our Cases With Inflammatory Bowel Disease. Endoscopy 2013;21:15-8.

C9: Yeşil A, Şenateş E, Kayataş K, Et Al. The Success Of Combination Treatment in The Management of A Patient with Hereditary Hemorrhagic Telangiectasia. Endoscopy 2013;21:22-4.

C10. Fatih DEMİRCAN, Faruk KILINC, Nevzat GOZEL, Banu Erkalma ŞENATEŞ, Ebubekir ŞENATEŞ. The Evaluation of Mean Platelet Volume in Hepatitis C Infection. Doi: 10.4274/Vhd.65365 Viral Hepatitis Journal 2014; 20(1): 11-14.

C11. Çakıcı V, Yorulmaz E, Mutlu HH, et al. The evaluation of serum folate and B12 levels as markers of liver metastases in stomach and colon cancer. Endoscopy Gastrointestinal 2014; 22: 25-8.

C12. Kaymaz Tahra S, Çolak Y, Şenateş E, et al. The implication of new oral anticoagulant agents in gastrointestinal bleeding. Endoscopy Gastrointestinal 2016;24:29-35.

C13. Şenateş E, Çolak Y. Exocrine Pancreatic Insufficiency. Turkiye Klinikleri J Gastroenterohepatol-Special Topics 2017;10(3):170-4.

 

D. Papers Presented at National Scientific Meetings and Published in Proceedings

D1. Bayoğlu İ.V., Şenateş E, Yeşil A, Demirtunç R., "The Relationship Between Red Cell Distribution Width (RDW) and Disease Activity in Crohn's Disease and Ulcerative Colitis", in the Conference Proceedings of the 27th National Gastroenterology Week, pp. 24, Antalya, Turkey, November 2010.

D2. Yeşil E.E., Şenateş E, Yeşil A, Sevinç C, Tufan F, Özdemir A, "Is Serum Homocysteine Elevated in Patients Using Proton Pump Inhibitors?", in the Conference Proceedings of the 27th National Gastroenterology Week, pp. 27, Antalya, Turkey, November 2010.

D3. Yılmaz Y, Şenateş E, Ayyıldız T, Çolak Y, Öztürk O, Yönal O, Kurt R, Eminler A.T., Tuncer İ, Övünç A.O.K., "Characterization of Non-Alcoholic Fatty Liver Disease Unrelated to Metabolic Syndrome: A Multicenter Study", in the Conference Proceedings of the 27th National Gastroenterology Week, pp. 57, Antalya, Turkey, November 2010.

D4. Şenateş E, Coşgun S, Altunöz M.E., Bahadır Ö, Yılmaz Y, Çolak Y, Öztürk O, Enç F.Y., Övünç A.O.K., "Patients Perceive Upper Gastrointestinal Endoscopy as More Difficult Than It Actually Is", in the Conference Proceedings of the 27th National Gastroenterology Week, pp. 118, Antalya, Turkey, November 2010.

D5. Şenateş E, Atamer A, Masatlıoğlu H.S., Akdoğan M.F., Atasoy M, Övünç A.O.K., "A Case of Polyarteritis Nodosa Initially Mimicking Pyelonephritis and Later Diagnosed with Inflammatory Bowel Disease", in the Conference Proceedings of the 27th National Gastroenterology Week, pp. 153, Antalya, Turkey, November 2010.

D6. Şenateş E, Yılmaz Y, Çolak Y, Öztürk O, Altunöz M.E., Kurt Ramazan, Özkara S, Aksaraya S, Tuncer İ, Övünç A.O.K., "Increased Serum Hepcidin Levels in Individuals with Biopsy-Proven Non-Alcoholic Fatty Liver Disease", in the Conference Proceedings of the 27th National Gastroenterology Week, pp. 165, Antalya, Turkey, November 2010.

D7. Sezikli M, Çetinkaya Z.A., Güzelbulut F, Gökden Y, Yaşar B, Şenateş E, Coşgun S, İnce A.T., Kurdaş O.Ö., "How Suitable Are Patients Diagnosed with Hepatocellular Carcinoma for Liver Transplantation at the Time of Diagnosis?" in the Congress Book of the 6th Hepato Gastroenterology Congress, pp. 133, Antalya, Turkey, September 2009.

D8. Özdil K, Çalhan T, Kahraman R, Demirdağ H, Şahin A, Yüzbaşıoğlu B, Demirsoy H, Şenateş E, Sökmen H.M., "Comparison of Different Antibiotic and Probiotic Combinations in Helicobacter pylori Eradication" in the Congress Book of the 7th Hepato Gastroenterology Congress, pp. 271, Antalya, Turkey, September 2010.

D9. Şentürk H, Şenateş E, Hatemi İ, Canbakan B, Özbay G, "A Case of Good Syndrome Controlled with Plasmapheresis" in the Proceedings of the 23rd National Gastroenterology Congress, pp. 271, Istanbul, Turkey, November 2006.

D10. Sayılır A, Şenateş E, Hatemi İ, Baysal B, Coşgun S, Erzin Y, Çelik A.F., "Can Corticosteroid Response Be a Good Predictor of Azathioprine Response in Steroid-Naive Crohn's Disease Patients?" in the Proceedings of the 23rd National Gastroenterology Congress, pp. 21, Istanbul, Turkey, November 2006.

D11. Baysal B, Hatemi İ, Şenateş E, Erzin Y, Çelik A.F., "Evaluation of Montreal Classification and Change in Disease Behavior in Patients with Inflammatory Bowel Disease" in the Proceedings of the 23rd National Gastroenterology Congress, pp. 21, Istanbul, Turkey, November 2006.

D12. Coşkun S, Şenateş E, Hatemi İ, Baysal B, Çelik A.F., "The Clinical Forms of Gas in Patients Admitted to the Gastroenterology Clinic and Its Value in the Discrimination of Organic/Functional Diseases," in the Proceedings of the 23rd National Gastroenterology Congress, pp. 120, Istanbul, Turkey, November 2006.

D13. Baysal B, Hatemi İ, Şenateş E, Güneş M, Erzin Y, Tuncer M, Bal K, Çelik A.F., "Extraintestinal Involvement and Findings in Crohn's Disease: Data from a Single Center," in the Proceedings of the 23rd National Gastroenterology Congress, pp. 147, Istanbul, Turkey, November 2006.

D14. Hatemi İ, Baysal B, Şenateş E, Erzin Y, Çelik A.F., "Azathioprine Toxicity in Inflammatory Bowel Disease: A 7-Year Polyclinic Experience," in the Proceedings of the 23rd National Gastroenterology Congress, pp. 29, Istanbul, Turkey, November 2006.

D15. Baysal B, Doğusoy G, Hatemi İ, Şenateş E, İpek T, Şentürk H, Tuncer M, "A Gastrointestinal Stromal Tumor Case Containing Ring Cells with Stones" in the Proceedings of the 3rd Hepato Gastroenterology Congress, p. 95, Antalya, Turkey, September 2006.

D16. Akın P, Mihmanlı İ, Kantarcı F, Hatemi İ, Şenateş E, Domaniç N, "Carotid Atherosclerosis in Cirrhotic Patients" in the Proceedings of the 23rd National Gastroenterology Congress, pp. 226, Istanbul, Turkey, November 2006.

D17. Baysal B, Hatemi İ, Şenateş E, Erzin Y, Çelik A.F., "Bone Mineral Density in Steroid-Naive Crohn's Disease" in the Proceedings of the 23rd National Gastroenterology Congress, pp. 260, Istanbul, Turkey, November 2006.

D18. Şenateş E, Baysal B, Hatemi İ, Coşkun M, Tuncer M, Yurdakul İ, "A Case of Celiac Disease with Severe Abdominal Pain" in the Proceedings of the 3rd Hepato Gastroenterology Congress, pp. 125, Antalya, Turkey, September 2006.

D19. Çolak Y, Karabay C.Y., Tuncer İ, Kocabay G, Kalaycı A, Şenateş E, Öztürk O, Doğanay L, Kızıltaş Ş, Enç F.Y., Ulaşoğlu C, Övünç O., "Evaluation of Epicardial Fat Thickness and Carotid Artery Intima-Media Thickness in Cases of Non-Alcoholic Fatty Liver Disease," in the Abstract Book of the 8th National Hepatology Congress, p. 170 (Best Poster Award), Ankara, Turkey, June 2011.

D20. Tabak Ö, Şenateş E, Canbakan B, Arslan A, Özaras R, Çelik A, "Etiology of Polyserositis in Acid-Hospitalized Patients," in the Proceedings of the 12th National Internal Medicine Congress, p. 119, Antalya, Turkey, October 2010.

D21. Yılmaz Y, Kurt R, Gürdal A, Alahdab Y.Ö., Yönal O, Şenateş E, Polat N, Eren F, İmeryüz N, "Serum Vaspin Levels and Epicardial Fat Thickness are Associated with Impaired Coronary Flow Reserve in Non-Alcoholic Fatty Liver Disease," in the Abstract Book of the 8th National Hepatology Congress, pp. 28-29, Ankara, Turkey, June 2011.

D22. Yılmaz Y, Eren Y, Kurt R, Yönal O, Polat Z, Şenateş E, Bachae M, İmeryüz N., "Serum Galectin-3 Levels are Associated with Body Mass Index but Do Not Change in Non-Alcoholic Fatty Liver Disease," in the Abstract Book of the 8th National Hepatology Congress, pp. 128-129, Ankara, Turkey, June 2011.

D23. Yusuf Yılmaz, Fatih Eren, Yaşar Çolak, Ebubekir Şenateş, Çiğdem Ataizi Çelikel, Neşe İmeryüz. "Hepatic Expression and Serum Levels of Syndecan-1 (CD138) in Non-Alcoholic Fatty Liver Disease Patients," in the Proceedings of the 29th National Gastroenterology Congress, pp. 253-254, Antalya, Turkey, November 2012.

D24. Mustafa Erhan Altunöz, Ebubekir Şenateş, Atakan Yeşil, Mustafa İhsan Uslan. "Sequential Therapy in Helicobacter pylori Eradication," in the Proceedings of the 29th National Gastroenterology Congress, p. 153, Antalya, Turkey, November 2012.

D25. Nesliar Eser Vardareli, Yusuf Yılmaz, Yaşar Çolak, Ebubekir Şenateş, Nurdan Tözün. "The Importance of FibroScan Use in the Evaluation of Fibrosis in Non-Alcoholic Fatty Liver Disease," in the Proceedings of the 29th National Gastroenterology Congress, p. 265, Antalya, Turkey, November 2012.

D26. Oğuzhan Öztürk, Yaşar Çolak, Hamdi Levent Doğanay, Hak Celal Ulaşoğlu, Feruze Yılmaz Enç, Güralp Taşan, Şafak Sertel Kızıltaş, Yusuf Yılmaz, Ebubekir Şenateş, İlyas Tuncer. "The Importance of Lectin-Like Low-Density Lipoprotein Receptor-1 Levels as a Biomarker and Its Correlation with Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease," in the Proceedings of the 29th National Gastroenterology Congress, p. 260, Antalya, Turkey, November 2012.

D27. Yusuf Yılmaz, Talat Ayyıldız, Hakan Akın, Yaşar Çolak, Oğuzhan Öztürk, Ebubekir Şenateş, İlyas Tuncer, Enver Dolar. "Gallstone Disease Is Not an Independent Predictor of Non-Alcoholic Steatohepatitis or Fibrosis in Non-Alcoholic Fatty Liver Disease," in the Proceedings of the 29th National Gastroenterology Congress, p. 41, Antalya, Turkey, November 2012.

D28. Yusuf Yılmaz, Talat Ayyıldız Yaşar Çolak, Ebubekir Şenateş, Mahmut Arabul, Belkıs Ünsal, İlyas Tuncer, Enver Dolar. "The Association Between Hypothyroidism and the Severity of Non-Alcoholic Fatty Liver Disease: A Multicenter Study," in the Proceedings of the 29th National Gastroenterology Congress, pp. 41-42, Antalya, Turkey, November 2012.

D29. Ceylan Bahadır, Mete Bilgül, Özgüneş Nail, Alper Gündüz, Aslan Turan, Şenateş Ebubekir, İnci Ayşe, Çolak Onur, Özaras Reşat, Tabak Fehmi. "The Relationship Between Mean Platelet Volume (MPV) and Platelet Distribution Width (PDW) with Liver Fibrosis Score in Chronic HBV Infection," in the Proceedings of the 11th National Viral Hepatitis Congress, pp. 168-169, Antalya, Turkey, April 2012.

D30. Erdem Levent, Mete Bilgül, Ceylan Bahadır, Özgüneş Nail, Gündüz Alper, Kumbasar Hayat, Çağatay Atahan, Höktürk Kadir, Koçak Funda, Aslan Turan, Şenateş Ebubekir, Kara Cengiz, Çolak Onur, Özaras Reşat, İnci Ayşe, Tabak Fehmi. "Evaluation of the Effectiveness of Peginterferon Treatment in Chronic Hepatitis B: Real-Life Data from the REALIST Study," in the Proceedings of the 11th National Viral Hepatitis Congress, p. 167, Antalya, Turkey, April 2012.

D31. Kumbasar Karaosmanoğlu Hayat, Mete Bilgül, Ceylan Bahadır, Özgüneş Nail, Gündüz Alper, Çağatay Atahan, Göktürk Kadir, Erdem Levent, Koçak Funda, Görenek Levent,i Akkoyunlu Yasemin, Şenateş Ebubekir, Çolak Onur, Özarasa Reşat, Altuntaş Aydın Özlem, Tabak Fehmi. "High Serum Alpha-Fetoprotein Levels and Associated Factors in Patients with Chronic Hepatitis B," in the Proceedings of the 11th National Viral Hepatitis Congress, pp. 160, Antalya, Turkey, April 2012.

D32. Özgüneş Nail, Mete Bilgül, Ceylan Bahadır, Gündüz Alper, Kumbasar Karaosmanoğlu Hayat, Kapamz Mahir, Göktürk Kadir, Erdem Levent, Koçak Funda, Görenek Levent, Akkoyunlu Yasemin, Alkım Canan, Şenateş Ebubekir, Çolak Onur, Özaras Reşat, Tabak Fehmi. "Evaluation of the Second-Year Results of Lamivudine Treatment in Naive Chronic Hepatitis B Patients: Real-Life Data from the REALIST Study," in the Proceedings of the 11th National Viral Hepatitis Congress, p. 159, Antalya, Turkey, April 2012.

D33. Mete Bilgül, Ceylan Bahadır, Özgüneş Nail, Gündüz Alper, Altuntaş Aydın Özlem, Çağatay Atahan, Göktürk Kadir, Erdem Levent, Koçak Funda, Görenek Levent, Aslan Turan, Şenateş Ebubekir, Özaras Reşat, Çolak Onur, Tabak Fehmi. "Comparison of Entecavir and Tenofovir in Naive Chronic Hepatitis B Patients: Real-Life Data from the REALIST Study," in the Proceedings of the 11th National Viral Hepatitis Congress, pp. 155-156, Antalya, Turkey, April 2012.

D34. Tabak Fehmi, Mete Bilgül, Ceylan Bahadır, Özgüneş Nail, Gündüz Alper, Kumbasar Karaosmanoğlu Hayat, Çağatay Atahan, Göktürk Kadir, Erdem Levent, Koçak Funda, Görenek Levent, Aslan Turan, Şenateş Ebubekir, Fincancı Muzaffer, Özaras Reşat. "Analysis of Virological Parameters in Chronic Hepatitis B Patients," in the Proceedings of the 11th National Viral Hepatitis Congress, p. 153, Antalya, Turkey, April 2012.

D35. Şeyma Meliha Su Dur, Ebubekir Şenateş, Dilan Bektaş, Mehmet Emin Adin, Mehmet Sıddık Yıldız, Hakan Önder. "A Rare Extraintestinal Complication of Crohn's Disease: Portal Vein Thrombosis," in the e-Poster Abstracts of the 33rd National Radiology Congress, P038, Antalya, Turkey, November 2012.

D36. Yaşar Çolak, Sabriye Gülçin Bozbey, Ebubekir Şenateş, Oğuzhan Öztürk, Levent Doğanay, Banu Mesci, İhsan Kuru, Yusuf Yılmaz, İlyas Tuncer. "Evaluation of Gallbladder Dynamics in Patients with Non-Alcoholic Fatty Liver Disease," in the Proceedings of the 9th National Hepatology Congress, p. 234, Istanbul, Turkey, May-June 2013.

D37. Yusuf Yılmaz, Talat Ayyıldız, Hakan Akın, Yaşar Çolak, Oğuzhan Öztürk, Ebubekir Şenateş, İlyas Tuncer, Enver Dolar. "Gallstone Disease Is Not an Independent Predictor of Non-Alcoholic Steatohepatitis or Fibrosis in Non-Alcoholic Fatty Liver Disease," in the Proceedings of the 29th National Gastroenterology Congress, p. 41, Antalya, Turkey, November 2012.

D38. Banu Erkalma Şenateş, Mehmet Serdar Yıldırım, Ebubekir Şenateş. "Symptomatic Hypocalcemia During Intravenous Zoledronic Acid Treatment for Osteoporosis: A Case Report," in the Proceedings of the 15th National Internal Medicine Congress, p. 237, Belek, Antalya, Turkey, October 2013.

D39. Yaşar Çolak, Sabriye Gülçin Bozbey, Ebubekir Şenateş, Oğuzhan Öztürk, Levent Doğanay, Banu Mesci, İhsan Kuru, Yusuf Yılmaz, İlyas Tuncer. "Evaluation of Gallbladder Dynamics in Patients with Non-Alcoholic Fatty Liver Disease," in the Proceedings of the 9th National Hepatology Congress, p. 234, Istanbul, Turkey, May-June 2013.

D40. Şafak Kızıltaş, Pınar Ata, Yaşar Çolak, Banu Mesçi, Ebubekir Şenateş, Feruze Enç, Celal Ulaşoğlu, İlyas Tuncer, Aytekin Oğuz. "Is TLR-4 Gene Polymorphism Protective Against the Development of NAFLD in Humans?" in the Proceedings of the 9th National Hepatology Congress, p. 231, Istanbul, Turkey, May-June 2013.

D41. Mehmet Veysi Bahadır, Mesut Gül, Ebubekir Şenateş, Abdullah Oğuz, Hüseyin Büyükbayram, Eyyup Öner, Bilsel Baç. "A Rare Duodenal Mass: Brunneroma - A Case Report," in the Proceedings of the 19th National Surgery Congress, Poster No: 0568, Antalya, Turkey, April 2014.

 

Adhésions

Association turque de recherche sur le foie (TKAD) (secrétaire du groupe de travail sur l'hépatite virale)

Association turque de gastroentérologie (TGD)

Inflammatory Bowel Disease Association (IBD Association)

Association turque de médecine interne (TİHUD)

Association de lutte contre les hépatites (VHSD) (membre du conseil d'administration), 2014-2022